脂肪性肝炎

Nonalcoholic steatohepatitis (NASH) is a severe form of fatty liver disease not caused by alcohol.
非酒精性脂肪性肝炎（NASH）是非酒精因素导致的一种严重类型的脂肪肝病。
The patient was diagnosed with steatohepatitis after several rounds of laboratory tests and imaging studies.
经过几轮实验室检测和影像学研究后，该患者被诊断为脂肪性肝炎。
Steatohepatitis can progress to cirrhosis if left untreated.
如果未经治疗，脂肪性肝炎可能会发展成肝硬化。
Lifestyle changes, including regular exercise and a healthy diet, can help manage and prevent the onset of steatohepatitis.
包括定期锻炼和健康饮食在内的生活方式改变有助于管理和预防脂肪性肝炎的发生。
Metabolic syndrome is often associated with an increased risk for developing steatohepatitis.
代谢综合症常常与患脂肪性肝炎的风险增加有关。
In some cases, steatohepatitis can be a reversible condition with appropriate medical intervention.
在某些情况下，通过适当的医疗干预，脂肪性肝炎是可以逆转的病症。
There is currently no specific medication approved for the treatment of nonalcoholic steatohepatitis.
目前尚无专门针对非酒精性脂肪性肝炎的获批药物。
Obesity and insulin resistance are considered major contributing factors to the development of steatohepatitis.
肥胖和胰岛素抵抗被认为是导致脂肪性肝炎发展的主要因素。
A biopsy may be required to definitively diagnose steatohepatitis and assess its severity.
可能需要进行活体组织检查以明确诊断脂肪性肝炎及其严重程度。
Research into the underlying mechanisms of steatohepatitis continues to advance our understanding of this complex disease.
对脂肪性肝炎潜在机制的研究不断加深我们对这种复杂疾病的理解。